English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 45071/58247 (77%)
造訪人次 : 2373718      線上人數 : 163
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    請使用永久網址來引用或連結此文件: http://libir.tmu.edu.tw/handle/987654321/36369


    題名: 以天然物為cap與氮-羥基肉桂酸醯胺結合作為組蛋白去乙醯酶抑制劑
    作者: 趙世偉
    貢獻者: 生藥學研究所
    日期: 2010
    上傳時間: 2010-10-20 12:42:21 (UTC+8)
    摘要: 研究顯示,組蛋白去乙醯酶抑制劑可望發展成為抗癌藥物,所有已知之組蛋白去乙醯酶抑制劑 (HDACi),從化學結構上包含了三個藥理活性基團:與鋅產生螯合之基團,疏水性鏈長,與疏水性的辨認部位。在本研究我們以具有疏水性之中藥成份蛇床子素 (osthole),來當作疏水性的辨認部位,合成一系列以N-hydroxycinnamides為基本架構之組蛋白去乙醯酶抑制劑 (HDACi),以探討蛇床子素 (osthole) 對於活性的效果。我們合成了九個結合蛇床子素 (osthole) 之N-hydroxacinnamides (9a~9i),並同時進行酵素抑制活性測試,發現化合物9d, 9e, 9g 具有顯著抑制子宮頸癌細胞萃取之組蛋白去乙醯酶 (HeLa cell nuclear extract HDAC) (IC50: 24.5, 20.0, 19.6 nM),其抑制活性相當於目前臨床上用於治療表皮T細胞淋胞癌 (cutaneous T-cell lymphoma, CTCL) 之組蛋白去乙醯酶抑制劑 (HDACi) suberoylanilide hydroxamic acid (SAHA, IC50: 24.5 nM),另外在組蛋白去乙醯酶1型 (HDAC1) 和組蛋白去乙醯酶6型 (HDAC6) 之酵素抑制活性上,化合物9d及9e具有和SAHA類似之活性,9g則對組蛋白去乙醯酶抑制劑1型 (HDAC1) 具有較好的選擇性,從乙醯化組蛋白3型 (acetylated H3) 與乙醯化α-微管蛋白 (acetylated α-tubulin) 之促進實驗中,化合物9d, 9e, 9g與SAHA相比較,9d有明顯之促進乙醯化之作用,顯示其具有好之細胞效果,接著將9d與SAHA進行分子結合模擬分析,顯示9d之蛇床子素 (osthole) 基團與SAHA的苯環都是作用酵素口袋表面疏水區,且蛇床子素 (osthole) 之側鏈經過修飾,可能產生對第Ⅱa型組蛋白去乙醯酶 (class Ⅱa HDAC) 選擇性抑制,以上這些結果證實,以蛇床子素 (osthole) 為疏水性cap與N-hydroxacinnamides相結合,可發展出有效之組蛋白去乙醯酶抑制劑 (HDACi)。

    Histone deacetylase (HDAC) inhibitors are regarded as promising therapeutics for the treatment of cancer. All reported HDAC inhibitors contain three pharmacophoric features: a zinc-chelating group, a hydrophobic linker, and a hydrophobic cap for surface recognition. In this study we investigated the effectiveness of osthole, a hydrophobic Chinese herbal compound, as the surface recognition cap in hydroxamate-based compounds as inhibitors of HDAC. Nine novel osthole-based N-hydroxycinnamides were synthesized and screened for enzyme inhibition activity. Compounds 9d, 9e, 9g exhibited inhibitory activities (IC50=24.5, 20.0, 19.6 nM) against nuclear HDACs in HeLa cells comparable to that of suberoylanilide hydroxamic acid (SAHA; IC50=24.5 nM), a potent inhibitor clinically used for the treatment of cutaneous T-cell lymphoma (CTCL). While compounds 9d and 9e showed SAHA-like activity towards HDAC1 and HDAC6, compound 9g was more selective for HDAC1. Compound 9d exhibited the best cellular effect, which was comparable to that of SAHA, of enhancing acetylation of either α-tubulin or histone H3. Molecular docking analysis showed that the osthole moiety of compound 9d may interact with the same hydrophobic surface pocket exploited by SAHA and it may be modified to provide class-specific selectivity. These results suggest that osthole is an effective hydrophobic cap when incorporated into N-hydroxycinnamide-derived HDAC inhibitors.
    關聯: 137頁
    描述: 中文摘要 i
    Abstract iii
    表目錄 vii
    流程圖目錄 viii
    圖目錄 ix
    一、緒論及研究目的 - 1 -
    二、結果與討論 - 9 -
    1. 化學合成 - 9 -
    2. 化合物 (9a-i) 對於抑制子宮頸癌細胞萃取之組蛋白去乙醯酶(HeLa cell nuclear extract histone deacetylase) 與抑制肝癌細胞 (HepG2) 生長之活性 - 12 -
    3. 化合物9d, 9e, 9g, 9i對組蛋白去乙醯酶1、6型 (HDAC1,-6)
    酵素抑制活性 - 14 -
    4. 化合物9d, 9e, 9g對於肝癌細胞HepG2α-微管蛋白乙醯化
    (acetylation α-tubulin) 及組蛋白三型乙醯化 (acetylation
    histone 3) 之影響 - 15 -
    5. 化合物9d之分子模擬(molecular modeling) - 17 -
    6. 化合物 9d 對於正常細胞之細胞毒性 - 19 -
    三、結論 - 20 -
    四、實驗部份 - 21 -
    I. 儀器與實驗材料 - 21 -
    1. 一般儀器及方法 - 21 -
    II. 化學合成步驟及物理資料 - 24 -
    III. 生物活性測試方法 - 49 -
    1. HDAC activity assay - 49 -
    2. The sulforhodamine B (SRB) growth inhibition assay - 50 -
    3. Western blot analysis - 51 -
    五、參考文獻(References) - 52 -
    六、附圖 - 60 -


    1.Matsudaira, P.T.L.; Harvey, F; Arnold, B.; Kaiser, C.;
    Monty, K.; Matthew, P.; Anthony, B.; Hidde, P., Molecular
    Cell Biology, 2007.
    2.Alberts, B., Molecular biology of the Cell. 2002, New
    York.
    3.Jemal, A.; Murray, T.; Ward, E.; Samuels, A.; Tiwari,
    R.C.; Ghafoor, A.; Feuer, E.J.; Thun, M.J., CA Cancer J.
    Clin., 2005, 55, 10.
    4.Harper, D.M.; Franco, E.L.; Wheeler, C.; Ferris, D.G.;
    Jenkins, D.; Schuind, A.; Zahaf, T.; Innis, B.; Naud, P.;
    De Carvalho, N.S.; Roteli-Martins, C.M.; Teixeira, J.;
    Blatter, M.M.; Korn, A.P.; Quint, W.; Dubin, G., Lancet,
    2004, 364, 1757.
    5.David, M.K.; Anna, C., Nature Reviews Microbiology, 2008,
    6, 211.
    6.Luger, K.; Mader, A.W.; Richmond, R.K.; Sargent, D.F.;
    Richmond, T.J., Nature, 1997, 389, 251.
    7.Davie, J.R., Curr Opin Genet Dev, 1998. 8, 173.
    8.Cress, W.D. ; Seto, E.; J Cell Physiol, 2000, 184, 1.
    9.Munshi, A.; Shafi, G.; Aliya. N.; Jyothy A., J. Genet.
    Genomics, 2009, 36, 75.
    10.Takayoshi, S.; Naoki, M., Curr. Med. Chem., 2006, 13,
    935.
    11.Herman, J.G.; Baylin, S.B., New. Engl. J. Med., 2004,
    350, 947.
    12.Roth, S.Y.; Denu, J.M.; Allis, C.D., Annu. Rev.
    Biochem., 2001, 70, 81.
    13.David, E.S.; Shelley, L.B., Microbiol. Mol. Biol. Rev.,
    2000, 64, 435.
    14.Hassig, C.A.; Schreiber, S.L., Curr. Opin. Chem. Biol,
    1997, 1, 300.
    15.Gregoire, S.; Yang, X.J., Mol. Cell. Biol., 2005, 25,
    2873.
    16.Khochbin, S.; Verdel, A.; Lemercier, C.; Seigneurin-
    Berny, D., Curr. Opin. Genet. Dev., 2001, 11, 162.
    17.Annemieke, J.M.; Ruijter, D.; Albert, H.; GENNIP, V.;
    CARON, H.N.; Kemp, S.; Andre, B.P.; Kuilenburg V.,
    Biochem. J., 2003, 370, 737.
    18.Gregoretti, I.V.; Lee, Y.M.; Goodson, H.V., J. Mol.
    Biol, 2004, 338, 17.
    19.Robertson, K.D.; Wolffe, A.P., Nature Rev. Genet., 2000,
    1, 11.
    20.Feng, Q.; Zhang, Y., Genes & Dev., 2001, 15, 827.
    21.Fuks, F.B.; Wendy, A.; Godin, N.; Kasai, M.; Kouzarides,
    T., EMBO J., 2001, 20, 2536.
    22.Verdin, E.; Dequiedt, F.; Kasler, H.G., Trends Genet.,
    2003, 19, 286.
    23.Mckinsey, T.A.; Zhang, C.L.; Lu, J.; Olson, E. N.,
    Nature, 2000, 408, 106.
    24.Wade, P.A., Hum Mol Genet, 2001, 10, 693.
    25.Hubbert, C.; Guardiola, A.; Shao, R.; Kawaguchi, Y.;
    Ito, A.; Nixon, A.; Yoshida, M.; Wang, X.F.; Yao, T.P.,
    Nature, 2002, 417, 455.
    26.North, B.J.; Marshall, B.L.; Borra, M.T.; Denu, J.M.;
    Verdin, E., Mol. Cell, 2003, 11, 437.
    27.Vigushin, D.M.; Coombes, R.C., Anti-Cancer Drugs, 2002,
    13, 1.
    28.Olaf, W. ; Hedwig, E.D.; Till, M.; Ina, O., Cancer
    Lett., 2009, 277, 8.
    29.Abraham, J., Community Oncology, 2007, 4, 384.
    30.Glaser, K.B.; Li, J.; Staver, M.J.; Wei, R.Q.; Albert,
    D.H.; Davidsen, S.K., Biochem Biophys Res Commun, 2003,
    310, 529.
    31.Paris, M.; Porcelloni, M.; Binaschi, M.; Fattori, D., J
    Med Chem, 2008, 51, 1505.
    32.Yoshida, M.; Kijima, M.; Akita, M.; Beppu, T., J Biol
    Chem, 1990, 265, 17174.
    33.Han, J.W.; Ahn, S.H.; Park, S.H.; Wang, S.Y.; Bae, G.U.;
    Seo, D.W.; Kwon, H. K.; Hong, S.; Lee, H.Y.; Lee, Y.W.;
    Lee, H.W., Cancer Res, 2000, 60, 6068.
    34.Yoshida, M.; Horinouchi, S.; Beppu, T., BioEssays, 1995,
    17, 423.
    35.Closse, A.; H. R., Helv. Chim. Acta, 1974, 57, 553.
    36.Kawai, M.; Rich, D.H.; Walton, J.D., Biochem. Biophys.
    Res. Comm., 1983, 111, 398.
    37.Itazaki, H.; Nagashima, K.; Sugita, K.; Yoshida, H.;
    Kawamura, Y.; Yasuda, Y.; Matsumoto, K.; Ishii, K.;
    Uotani, N.; Nakai, H.; Terui, A.; Yoshimatsu, S.;
    Ikenishi, Y.; Nakagawa, Y., J. Antibiot., 1990, 63, 1524.
    38.Furumai, R.; Matsuyama, A.; Kobashi, N.; Lee, K.H.;
    Nishiyama, M.; Nakajima, H.; Nakajima, A.; Komatsu, Y.;
    Nishino, N.; Yoshida, M.; Horinouchi, S., Cancer Res.,
    2002. 62, 4916.
    39.Fournel, M.; Trachy-Bourget, M.C.; Theresa Y.P.; Kalita,
    A., Cancer Res., 2002, 62, 4325.
    40.Richon, V.M.; Webb, Y.; Merger, R.; Sheppard, T.;
    Jursic, B.; Ngo, L.; Civoli, F.; Breslow, R.; Rifkind,
    R.A.; Marks, P.A., Proc. Natl. Acad. Sci. U.S.A., 1996,
    93, 5705.
    41.Richon, V.M.; Emiliani, S.; Verdin, E.; Webb, Y.;
    Breslow, R.; Rifkind R.A.; Paul, A.M., Proc. Natl. Acad.
    Sci. U.S.A., 1998, 95, 3003.
    42.Cohen, L.A.; Amin, S.; Marks, P.A.; Rifkind, R.A.;
    Desai, D.; Richon, V.M., Anticancer Res., 1999, 19, 4999.
    43.Wittich, S.; Scherf, H.; Xie, C.; Brosch, G.; Loidl, P.;
    Gerhauser, C.; Jung, M., J. Med. Chem., 2002, 45, 3296.
    44.Furumai, R.; Komatsu, Y.; Nishino, N.; Khochbin, S.;
    Yoshida, M.; Horinouchi, S., Proc. Natl. Acad. Sci.
    U.S.A., 2001, 98, 87.
    45.Komatsu, Y.; Tomizaki, K.Y.; Tsukamoto, M.; Kato, T.;
    Nishino, N.; Sato, S.; Sato, T.; Tsuruo, T.; Furumai,
    R.; Yoshida, M.; Horinouchi, S.; Hayashi, H., Cancer
    Res., 2001, 61, 4459.
    46.Plumb, J.A.; Finn, P.W.; Williams, R.J.; Bandara, M.J.;
    Romero, M.R.; Watkins, C.J.; Thangue, N.B.; Brown, R.,
    Mol. Cancer. Ther., 2003, 2, 721.
    47.Remiszewski, S.W., Curr. Med. Chem., 2003, 10, 2393.
    48.Remiszewski, S.W.; Sambucetti, L.C.; Bair, K.W.;
    Bontempo, J., J. Med. Chem., 2003, 46, 4609.
    49.Atadja, P.; Gao, L.; Kwon, P.; Trogani, N.; Walker, H.;
    Hsu, M., Cancer Res., 2004, 64, 689.
    50.Bouchain, G.; Leit, S.; Frechette, S.; Khalil, E.A.;
    Lavoie, R., J. Med. Chem., 2003, 46, 820.
    51.Besterman, J.M., Pacifichem, 2005.
    52.Ueda, H.; Nakajima, H.; Hori, Y.; Fujita, T.; Nishimura,
    M.; Goto, T.; Okuhara, M., J Antibiot., 1994, 47, 301.
    53.Richon, V.M.; Emiliani, S.; Verdin, E.; Webb, Y.;
    Breslow, R.; Rifkind, R.A.; Marks, P. A., Proc Natl Acad
    Sci U S A 1998, 95, 3003.
    54.Monks, A.; Hose, C.D.; Pezzoli, P.; Kondapaka, S.;
    Vansant, G.; Petersen, K. D.; Sehested, M.; Monforte,
    J.; Shoemaker, R.H., Anticancer Drugs, 2009, 20, 682.
    55.Wang, H.; Yu, N.; Song, H.; Chen, D.; Zou, Y.; Deng, W.;
    Lye, P.L.; Chang, J.; Ng, M.; Sun, E.T.; Sangthongpitag,
    K.; Wang, X.; Wu, X.; Khng, H.H.; Fang, L.; Goh, S.K.;
    Ong, W.C.; Bonday, Z.; Stunkel, W.; Poulsen, A.;
    Entzeroth, M., Bioorg. Med. Chem. Lett., 2009, 19, 1403.
    56.Bottomley, M.J.; Lo, S. P.; Di Giovine, P.; Cirillo, A.;
    Scarpelli, R.; Ferrigno, F.; Jones, P.; Neddermann, P.;
    De Francesco, R.; Steinkuhler, C.; Gallinari, P.; Carfi,
    A., J. Biol. Chem., 2008, 283, 26694.
    57.Nielsen, T.K.; Hildmann, C.; Dickmanns, A.;
    Schwienhorst, A.; Ficner, R., J. Mol. Biol, 2005, 354,
    107.
    58.Taunton, J.; Hassig, C.A.; Schreiber, S.L., Science,
    1996, 272, 408.
    59.Vaisburg, A.; Bernstein, N.; Frechette, S.; Allan, M.;
    Abou-Khalil E., Bioorg. Med. Chem. Lett., 2004, 14, 283.
    60.Bouchain, G.; Delorme, D., Curr. Med. Chem., 2003, 10,
    2359.
    61.Woo, S.H.; Frechette, S.; Khalil, E.A.; Bouchain, G.;
    Vaisburg, A.; Moradei, O.; Bernstein, N.; Leit, S.;
    Allan, M.; Fournel, M.; Trachy-Bourget, Z.; Besterman,
    J. M.; Delorme, D., J. Med. Chem., 2002, 45, 2877.
    62.Frey, R.R.; Wada, C.K.; Garland, R.B.; Curtin, M.L.;
    Michaelides, R.L.; Michaelides, J.; Pease, L.J.; Glaser,
    K.B.; Marcotte, P.A.; Bouska,J.J.; Murphy, S.S.;
    Davidsen, S.K., Bioorg. Med. Chem. Lett., 2002, 12, 3443.
    63.Finnin, M.S.; Donigian, J.R.; Cohen, A.; Richon, V.M.;
    Rifkind, R.A.; Marks, P.A.; Pavletich, N. P., Nature,
    1999, 401, 188.
    64.Somoza, J.R.; Skene, R.J.; Katz, B.A.; Mol, C.; Ho,
    J.D., Structure, 2004, 12, 1325.
    65.Vannini, A.; Volpari, C.; Filocamo, G.; Casavola, E. C.;
    Brunetti, M.; Renzoni, D.; Chakravarty, P.; Paolini, C.;
    De Francesco, R.; Gallinari, P.; Steinkuhler, C.; Di
    Marco, S., Proc. Natl. Acad. Sci., 2004, 101, 15064.
    66.Vannini, A.; Volpari, C.; Filocamo, G.; Casavola, E.C.;
    Brunetti, M.; Renzoni, D.; Chakravarty, P.; Paolini, C.;
    De Francesco, R.; Gallinari, P.; Steinkuhler, C.; Di
    Marco, S., Proc. Natl. Acad. Sci. USA 2004, 101, 15064.
    67.Schuetz, A.; Min, J.; Allali-Hassani, A.; Schapira, M.;
    Shuen, M.; Loppnau, P.; Mazitschek, R.; Kwiatkowski,
    N.P.; Lewis, T.A.; Maglathin, R.L.; McLean, T. H.;
    Bochkarev, A.; Plotnikov, A.N.; Vedadi, M.; Arrowsmith,
    C.H., J Biol Chem, 2008, 283, 11355.
    68.You, L.; Feng, S.; An, R.; Wang, X., Nat. Prod. Commun.,
    2009, 4, 297.
    69.Huang, R.L.; Chen, C.C.; Huang, Y.L.; Hsieh, D.J.; Hu,
    C.P.; Chen, C.F.; Chang, C., Hepatology, 1996, 24, 508.
    70.Zhang, Q.; Qin, L.; He, W.; Van Puyvelde, L.; Maes, D.;
    Adams, A.; Zheng, H.; De Kimpe, N., Planta Med., 2007,
    73, 13.
    71.Fujioka, T.; Furumi, K.; Fujii, H.; Okabe, H.; Mihashi,
    K.; Nakano, Y.; Matsunaga, H.; Katano, M.; Mori, M.,
    Chem. Pharm. Bull., 1999, 47, 96.
    72.Kuo, P.L.; Hsu, Y.L.; Chang, C.H.; Chang, J.K., J.
    Pharmacol. Exp. Ther., 2005. 314, 1290.
    73.Tosun, A.; Akkol, E.K.; Yesilada, E., Z. Naturforsch.
    C., 2009, 64, 56.
    顯示於類別:[生藥學研究所] 博碩士論文

    文件中的檔案:

    沒有與此文件相關的檔案.



    在TMUIR中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    著作權聲明 Copyright Notice
    • 本平台之數位內容為臺北醫學大學所收錄之機構典藏,包含體系內各式學術著作及學術產出。秉持開放取用的精神,提供使用者進行資料檢索、下載與取用,惟仍請適度、合理地於合法範圍內使用本平台之內容,以尊重著作權人之權益。商業上之利用,請先取得著作權人之授權。

      The digital content on this platform is part of the Taipei Medical University Institutional Repository, featuring various academic works and outputs from the institution. It offers free access to academic research and public education for non-commercial use. Please use the content appropriately and within legal boundaries to respect copyright owners' rights. For commercial use, please obtain prior authorization from the copyright owner.

    • 瀏覽或使用本平台,視同使用者已完全接受並瞭解聲明中所有規範、中華民國相關法規、一切國際網路規定及使用慣例,並不得為任何不法目的使用TMUIR。

      By utilising the platform, users are deemed to have fully accepted and understood all the regulations set out in the statement, relevant laws of the Republic of China, all international internet regulations, and usage conventions. Furthermore, users must not use TMUIR for any illegal purposes.

    • 本平台盡力防止侵害著作權人之權益。若發現本平台之數位內容有侵害著作權人權益情事者,煩請權利人通知本平台維護人員([email protected]),將立即採取移除該數位著作等補救措施。

      TMUIR is made to protect the interests of copyright owners. If you believe that any material on the website infringes copyright, please contact our staff([email protected]). We will remove the work from the repository.

    Back to Top
    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋